Sections & Products

Main > A1. CORP. INDEX. P-Pm > Pfizer /P C2

This data is not available for free

Pfizer /P C2's subsections

1999. 10.25.1999. (Inhaled Insulin)

2001. 03.12.2001. (Comments)

2001. 11.20.2001. (Comments)

2001. 11.20.2001. (Compu. Chemist)

2002. 01.03.2002. (Tripos Inc Deal)

2002. 05.27.2002. (Process Chem.)

2002. 06.10.2002. (Collaboration)

2002. 07.22.2002. (Executive)

2002. 07.22.2002. (Major Prodts)

2002. 07.22.2002. (No. Empl 135,000

2002. 07.22.2002. (Pharmacia Acq.)

2002. 07.22.2002. (Psychiatry)

2002. 07.22.2002. (R&D Spend 7.5B)

2002. 08.26.2002. (Tech. Program)

2002. 09.02.2002. (Collaboration/1)

2002. 09.02.2002. (Collaboration/2)

2002. 09.02.2002. (Investment)

2002. 09.16.2002. (Veterinary)

2002. 09.23.2002. (Off Patent Drug)

2002. 10.07.2002. (Statins)

2002. 10.14.2002. (Subscriber of)

2002. 10.28.2002. (LawSuit)

2002. 11.11.2002. (CombiChem)

2002. 11.11.2002. (Member of)

2002. 11.11.2002. (Process Chem.)

2002. 11.21.2002. (Cardio/CETP Inh)

2002. 12.02.2002. (Inhaled Insulin)

2002. 12.02.2002. (M&A/Hist. Co. s)

2002. 12.02.2002. (Metabonomics)

2003. 01.06.2003. (Ophthalmology)

2003. 01.13.2003. (Collaboration)

2003. 01.27.2003. (Business Sale)

2003. 01.29.2003. (Pneum. Marker)

2003. 02.03.2003. (AIDS)

2003. 02.03.2003. (Collaboration)

2003. 02.26.2003. (Peakdale Deal)

2003. 03.03.2003. (Market Share 11%

2003. 03.18.2003. (Urology)

2003. 03.24.2003. (Pharmacia Acq.)

2003. 04.28.2003. (R&D Closures)

2003. 05.19.2003. (Parent of)

2003. 05.19.2003. (SARS)

2003. 06.09.2003. (Diosynth)

2003. 06.09.2003. (Nektar T.)

2003. 06.30.2003. (Partner in JV.:)

2003. 07.07.2003. (Diag. Unit Sale)

2003. 07.14.2003. (Antibiotics/Vet)

2003. 07.28.2003. (Executive)

2003. 07.28.2003. (Start-Up Co.)

2003. 08.12.2003. (Lynx T. Deal)

2003. 08.24.2003. (Urology)

2003. 09.29.2003. (Process Chem.)

2003. 10.06.2003. (Start-Up Co.)

2003. 10.20.2003. (Mental Health)

2003. 10.30.2003. (ImmunoSuppress)

2003. 11.17.2003. (Donation)

2003. 11.27.2003. (AD)

2003. 12.22.2003. (Corp. Acq.)

2004. 02.16.2004. (ArQule Deal)

2004. 02.16.2004. (ChemBridge Deal)

2004. 02.16.2004. (Discov Tool/PET)

2004. 02.16.2004. (Executives)

2004. 02.23.2004. (DPI Deal)

2004. 03.15.2004. (Cardio.)

2004. 04.08.2004. (Cardio.)

2004. 05.03.2004. (Chiral Catalysi)

2004. 07.06.2004. (Neurology)

2004. 08.23.2004. (Generic Co Sale)

2004. 09.06.2004. (Generic Co Sale)

2004. 11.22.2004. (Metab Syndrome)

2004. 11.22.2004. (Tripos Deal)

2004. 12.13.2004. (COX-2 Inhibitor)

2004. 12.31.2004. (Neurology)

2005. 01.24.2005. (Ambit Bio Deal)

2005. 02.07.2005. (Drug Safety)

2005. 03.03.2005. (Inhaled Insulin)

2005. 03.07.2005. (DowPharma Deal)

2005. 03.14.2005. (DowPharma Deal)

2005. 04.04.2005. (Coley Pharma.)

2005. 05.30.2005. (Avantium Tech.)

2005. 05.30.2005. (Isis Pharma.)

2005. 05.30.2005. (MicroChemistry)

2005. 06.06.2005. (Codexis)

2005. 06.06.2005. (ImPotence)

2005. 06.06.2005. (Renovis)

2005. 06.06.2005. (Vanilloid R.)

2005. 06.13.2005. (Neurology)

2005. 09.05.2005. (Chiral Catalysi)

2005. 10.03.2005. (Gene Logic)

2005. 10.17.2005. (AtorvaStatin>UK)

2005. 11.21.2005. (CCR2 AntAgonist)

2005. 11.22.2005. (Ophthalmology)

2006. 01.09.2006. (Perlegen Sci.)

2006. 02.27.2006. (Singapore)

2006. 05.08.2006. AIDS>Monogram Bio

2006. 06.26.2006. (Consumer Health)

2006. 08.28.2006. Sr VP Science &

2006. 09.01.2006. (Ca Blocker)

2006. 09.18.2006. (AD>RAGE Inh.)

2006. 12.02.2006. (Good Cholester+)

2006. 12.04.2006. Scripps Research

2007. 04.09.2007. Caliper Life

2007. 04.16.2007. Melior Discovery

2007. 06.25.2007. Sr Research

2007. 06.25.2007. VP Chemistry &

2007. 07.02.2007. Sr Manager Of

2007. 07.25.2007. (Pneumology)

2007. 08.20.2007. (VP Of Oncology)

2007. 09.03.2007. (BMS>DGAT-1 Inh.)

2007. 10.08.2007. (Clinical Dev.)

2007. 10.30.2007. (Schizophrenia)

2007. 12.03.2007. (Head Molecular)

2007. 12.18.2007. (Corp. Acq.)

2008. 01.16.2008. (Orthopaedics)

2008. 02.04.2008. Wash. State Uni.

2008. 02.11.2008. Personalized Med.

2008. 02.21.2008. (AtorvaStatin>NL)

2008. 02.28.2008. (AtorvaStatin E)

2008. 03.03.2008. (Corp. Acq.)

2008. 03.03.2008. (VP of Strategy)

2008. 03.07.2008. (COX-2 Inhibitor)

2008. 03.10.2008. CEO

2008. 03.10.2008. Pres Global R&D

2008. 03.20.2008. (AtorvaStatin E)

2008. 03.31.2008. (AtorvaStatin E)

2008. 04.01.2008. (Onco.>Melanoma)

2008. 04.14.2008. AntiBacterials

2008. 04.16.2008. Onco.>Brain C.

2008. 04.17.2008. CA Patent

2008. 04.24.2008. Dividend

2008. 04.25.2008. Diabetes R&D

2008. 04.28.2008. Director Library

2008. 04.30.2008. AtorvaStatin>US

2008. 05.12.2008. Biologics

2008. 05.14.2008. VP Oncology Unit

2008. 05.20.2008. Five Prime Therap

2008. 05.27.2008. AtorvaStatin>AU

2008. 05.28.2008. Sr VP & General

2008. 06.02.2008. Onco.>Brain C.

2008. 06.02.2008. Onco.>NSCLC

2008. 06.02.2008. Onco.>Sarcoma

2008. 06.05.2008. Sr. VP Investor

2008. 06.10.2008. Blood Coag.>VTE

2008. 06.10.2008. Corp. Acq.

2008. 06.10.2008. UCSF Alliance

2008. 06.12.2008. Uni Penn Alliance

2008. 06.23.2008. Ophthalmology

2008. 09.22.2008. VP Strategy &

2008. 10.20.2008. MicroFluidics

2008. 11.10.2008. VP Research Labs

2008. 11.24.2008. CSO

2008. 11.24.2008. Regenerative

2008. 11.24.2008. WW Research

2008. 12.01.2008. Intl. Affairs

2008. 12.09.2008. Malaria

2009. 01.19.2009. Media Relations

2009. 04.12.2009. IN>Pfizer Ltd.

2009. 04.13.2009. 2 R&D Teams

2009. 04.22.2009. Malaria

2009. 04.27.2009. ADHD

2009. 04.27.2009. Endometriosis

2009. 05.21.2009. Aurobindo Pharma

2009. 05.25.2009. Informatics Head

2009. 05.30.2009. Onco.>NSCLC

2009. 05.31.2009. BioTherapeutics &

2009. 06.08.2009. Green Chem. Lead

2009. 06.22.2009. Quality VP

2009. 07.29.2009. Fudan Uni.

2009. 07.29.2009. Shanghai Institut

2010. 01.06.2010. Strides Arcolab

2010. 05.17.2010. Washington Uni.

2010. 06.14.2010. Rare Disease

2010. 06.22.2010. Onco.>AML

2010. 10.18.2010. IN>BioCon

2010. 10.20.2010. BR>Teuto

2010. 11.16.2010. UCSF

2011. 04.11.2011. Onco.>PI3K Inh.

2011. 04.20.2011. Shanghai Pharma.

2011. 05.20.2011. Blood Coag.

2011. 06.29.2011. RU>ChemRar

2011. 09.08.2011. AH Vacc. CN

2011. 09.08.2011. RA

2011. 10.26.2011. Medco

2011. 12.14.2011. Dacomitinib

2012. 02.15.2012. Neuro.>TTR-FAP

2012. 02.17.2012. Hisun Pharma.

2012. 02.27.2012. Alacer Corp. Acq.

2012. 02.29.2012. Blood Coag.

2012. 05.01.2012. Gaucher Dis.

2012. 05.01.2012. Settles Lawsuit

2012. 05.04.2012. Neuro.>Pain>HIV..

2012. 05.15.2012. Onco.>Kidney C.

2012. 05.23.2012. Pres. & Gen. Man.

2012. 05.24.2012. Neuro.>TTR-FAP

2012. 06.13.2012. Onco.>CSHL

2012. 06.21.2012. Neuro.>Pain +

2012. 07.19.2012. Endo>Osteoporosis

2012. 07.19.2012. Patent Litigation

2012. 07.23.2012. Neuro.>GAD

2012. 08.06.2012. Neuro.>AD

2012. 08.10.2012. Onco.>Kidney C.

2012. 08.13.2012. AH Bus. IPO File

2012. 08.13.2012. OTC Esomeprazole

2012. 09.07.2012. Mylan

2012. 10.05.2012. Pfizer IN

2012. 10.11.2012. Pain

2012. 10.17.2012. Onco.>Kidney C.

2012. 11.16.2012. Neuro.>Epilepsy

2012. 11.19.2012. Fibromyalgia

2012. 11.19.2012. Pneumo.>CF

2013. 01.14.2014. Psychiatry>ADHD

2013. 01.24.2013. Neuro.>MDD

2013. 01.24.2013. Nicotine Dep.

2013. 01.24.2013. Uro.>OAB

2013. 01.31.2013. Wins Patent Case

2013. 03.05. ReIssue Patent

2013. 03.10. CV.>STEMI>No HF

2013. 03.28. Onco.>CML

2013. 04.25. Rheuma.>JIA/JRA

2013. 05.20. Onco.>NHL

2013. 05.29. UCSF

2013. 06.12. PantoprAzole Patent

2013. 07.29. Sep. 3 Bus. Segments

2013. 08.13. Obesity & Diabetes

2013. 10.17. Onco.>NCCN

2013. 10.21. Neuro.>Pain>FM & DPN

2013. 10.22. Neuro.>Pain>O

2013. 11.21. Onco.>Melanoma

2013. 12.04. Data Access Portal

2013. 12.17. Group Pres.; Vaccines

2014. 01.27. Onco.>NSCLC>D

2014. 03.12. ReIssue Patent

2014. 03.25. Onco.>NSCLC>C

2014. 03.26. Children>SGA

2014. 03.27. CV.>LDL-C.>Redn.>By

2014. 03.28. GI>OTC Nexium� 24HR

2014. 05.01. Neuro.>Pain>O+N

2014. 05.12. $4.5 B Debt Offering

2014. 05.23. Derma.>Psoriasis

2014. 06.11. RA>Tofacitinib Citrate

2014. 06.16. Mass.>Cambridge>R&D

2014. 07.16. Acq. InnoPharma Inc.

2014. 07.16. Hemophilia B

2014. 07.30. Acq. Baxter>Vaccines

2014. 08.12. CN>PHN & pDPN

2014. 08.13. Pneumococcal Dis.

2014. 08.26. Onco.>NSCLC>Merck

2014. 09.29. Kyowa Hakko Kirin

2014. 10.29. Meningococcal B Dis.

2014. 11.17. Immuno Onco.>PD-L1 Ab

2014. 12.08. Spark Therapeutics

2015. 01.05. Acq. Redvax GmbH

2015. 02.05. Acq. Hospira

2015. 05.11. AM Pharma

2015. 09.24. Merck KGaA & Dako

2016. 01.04. Merck KGaA & Syndax

2016. 02.24. RA>Tofacitinib Citrate

2016. 04.20. CA>REXALL DRUGSTORE

2016. 05.10. Onco.>Breast C. P

2016. 05.16. Acq. Anacor Pharma

2016. 06.27. CN BioSimilars GE

2016. 08.01. Acq. Bamboo Therap.

2016. 08.19. Pain>OxycodoneHCl+

2016. 08.22. Acq. Medivation

2016. 08.24. AstraZeneca>Anti-Infe+

2016. 08.31. Onco.>NSCLC

2016. 12.14. Derma.>Eczema Adults

2017. 05.10. Hemophilia A

2017. 05.30. Meningococcal B Dis.

2017. 06.06. Cardio.>FAC

2017. 06.30. Onco.>ALL EU OK

2017. 08.17. Onco.>ALL USA OK

2018. 01.03. Sangamo

2018. 01.11. End NeuroSci. R&D

2018. 07.20. Onco.>CT>Neutropenia

2018. 09.04. Debt Notes

2018. 09.27. Onco.>NSCLC>D

2018. 10.16. Onco.>Breast C.

2018. 11.02. Onco.>NSCLC USA>OK

2018. 11.21. Onco.>AML

2019. 03.20. Vivet Therapeutics

2019. 04.03. Onco.>NSCLC>D

2019. 05.06. Cardio.>CM &

2019. 05.08. Acq. Therachon

2019. 05.16. Hematology

2019. 06.21. Onco.>Breast C.

2019. 06.28. Onco.>BioSimilar

2019. 07.23. Onco.>BioSimilar

2019. 10.28. Onco.>Advanced RCC

2019. 11.18. Inflammat.>BioSimilar

2019. 12.12. GI>UC

2020. 02.18. Cardio.>ATTR-CM

2020. 03.24. Derma.>Eczema Pediatr.

2020. 03.27. Bond

2020. 04.08. Onco.>CRC

2020. 06.11. Onco.>BioSimilar

2020. 09.28. Rheuma.>pcJIA

2020. 12.02. COVID-19 Vaccine>UK>OK

2020. 12.11. COVID-19 Vaccine>US>OK

2020. 12.21. COVID-19 Vaccine>EU>OK

2020. 12.28. COVID-19 Vaccine>EU>TM

2020. 12.28. Myovant Sciences

2021. 01.14. Onco.>ALK+ ALCL

2021. 02.05. Onco.>Breast C. Patent

2021. 03.23. COVID-19 Oral Inhibito

2021. 04.28. Acq. Amplyx Pharma.

2021. 07.22. Arvinas

2021. 08.23. Acq. Trillium

2021. 08.23. COVID-19 USA>Full OK

2021. 10.28. Endo.>pGHD

2021. 11.17. Acq. Trillium

2021. 12.13. Acq. Arena Pharma.

2021. 12.14. Rheuma.>AS>USA>OK

2022. 02.15. Endo.>Ped GHD>EU>OK

2022. 02.15. Pneumo.>Vaccine EU>OK

2022. 03.11. Acq. Arena Pharma

2022. 04.07. Acq. ReViral

2022. 04.27. Migraine EU>OK

2022. 05.10. Acq. BioHaven Pharma.

2022. 06.09. Acq. ReViral

2022. 07.21. Pneumo.>Vaccine CA>Ava

2022. 08.08. Acq. Global Blood ..

2022. 08.31. COVID-19 Vacc>USA>EUA

2022. 10.05. Acq. Global Blood ..

2023. 02.10. FDA Approves

2023. 03.10. Migraine>USA>OK

2023. 03.13. Acq. Seagen

2023. 04.27. USA FDA Approves

2023. 05.16. Debt Offering

2023. 05.25. Covid-19 Treat>USA>OK

2023. 05.31. RSV Prevn Vacc>USA>OK

2023. 08.14. Onco.>RRMM>USA>OK

2023. 08.21. RSV Prevn Vacc>USA>OK

2023. 08.24. RSV Prevn Vacc>EU>OK

2023. 09.11. COVID-19 vaccine>USA>

2023. 09.13. Onco.>RRMM>USA>Launch

2023. 09.19. EU CE Mark

2023. 10.12. Onco.>NSCLC>USA>OK

2023. 10.13. Gastro.>UC>USA>OK

2023. 10.19. MYFEMBREE�>CA>OK

2023. 12.04. Health Canada Approval

2023. 12.08. Onco.>RRMM>EU>OK

2023. 12.14. Acq. Seagen

2024. 01.03. Hemophilia B>CA>OK

2024. 01.04. Bivalent RSV Vac>CA>OK

2024. 01.08. Onco.>mCRPC>EU>OK

2024. 02.13. Onco.>RRMM>CA>OK

2024. 02.19. Gastro.>UC>EU>OK

2024. 03.13. EU Approves

Agricultural Div.

Angiosyn/P

BioSearch Italia/P

Farmitalia Carlo Erba S.p.A./P

Farmitalia Carlo Erba S.r.L./P

GD Searle/P

Goedecke AG/P

Greenstone Ltd. (Subsidiary)

Gruppo Lepetit SPA/P

Jouveinal/P

Kabi Pharmacia AB/P

KabiVitrum AB/P

Meridica/P

Monsanto Co./P (GD Searle)

Namic USA Corp./P

Patents

Pfizer Animal Health/P C2

Pfizer Incubator C2

Pfizer India C2

Pfizer Japan/P C2

Pfizer Venture Investments. C2

PfizerCentreSource C2

Research & Dev. C2

Searle Medidata/P

Talaria Therapeutics Inc/P

Upjohn Co./P

Warner Lambert/P

Web-Site (Brazil)

Z - OK

Pfizer /P C2's products
This section has no products